These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31786971)

  • 1. Elevated Blood Pressure in the Emergency Department: A Risk Factor for Incident Cardiovascular Disease.
    Oras P; Häbel H; Skoglund PH; Svensson P
    Hypertension; 2020 Jan; 75(1):229-236. PubMed ID: 31786971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
    Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
    Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visit-to-Visit Blood Pressure Variability and Mortality and Cardiovascular Outcomes Among Older Adults: The Health, Aging, and Body Composition Study.
    Wu C; Shlipak MG; Stawski RS; Peralta CA; Psaty BM; Harris TB; Satterfield S; Shiroma EJ; Newman AB; Odden MC;
    Am J Hypertens; 2017 Feb; 30(2):151-158. PubMed ID: 27600581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
    Thune JJ; Signorovitch J; Kober L; Velazquez EJ; McMurray JJ; Califf RM; Maggioni AP; Rouleau JL; Howlett J; Zelenkofske S; Pfeffer MA; Solomon SD
    Hypertension; 2008 Jan; 51(1):48-54. PubMed ID: 18025296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data.
    Lindh M; Banefelt J; Fox KM; Hallberg S; Tai MH; Eriksson M; Villa G; Svensson MK; Qian Y
    Eur Heart J Qual Care Clin Outcomes; 2019 Jul; 5(3):225-232. PubMed ID: 30649251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors.
    Whelton SP; McEvoy JW; Shaw L; Psaty BM; Lima JAC; Budoff M; Nasir K; Szklo M; Blumenthal RS; Blaha MJ
    JAMA Cardiol; 2020 Sep; 5(9):1011-1018. PubMed ID: 32936272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.
    Son JS; Choi S; Kim K; Kim SM; Choi D; Lee G; Jeong SM; Park SY; Kim YY; Yun JM; Park SM
    JAMA; 2018 Nov; 320(17):1783-1792. PubMed ID: 30398603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ideal cardiovascular health and incidence of atherosclerotic cardiovascular disease among Chinese adults: the China-PAR project.
    Han C; Liu F; Yang X; Chen J; Li J; Cao J; Li Y; Shen C; Yu L; Liu Z; Wu X; Zhao L; Hu D; Lu X; Wu X; Gu D
    Sci China Life Sci; 2018 May; 61(5):504-514. PubMed ID: 29721777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fasting blood glucose levels and blood pressure and treatment of diabetes and hypertension on the incidence of cardiovascular disease: a study of 740 patients with incident Type 2 diabetes with up to 30 years' follow-up.
    Jansson SP; Svärdsudd K; Andersson DK
    Diabet Med; 2014 Sep; 31(9):1055-63. PubMed ID: 24894815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of blood pressure categories according to the 2017 American College of Cardiology/American Heart Association hypertension guideline and long-term blood pressure change with incident cardiovascular disease in middle-aged and elderly Chinese: the Dongfeng-Tongji cohort study.
    Ma L; Guo W; Yang L; Lai X; Fang Q; Liu M; Yang H; Zhou L; Wang H; Xiao Y; He M; Guo H; Wang C; Zhang X
    J Hypertens; 2019 Oct; 37(10):2007-2014. PubMed ID: 31116159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino-Terminal Pro-B-Type Natriuretic Peptide Improves Discrimination for Incident Atherosclerotic Cardiovascular Disease Beyond Ambulatory Blood Pressure in Elderly Men.
    Skoglund PH; Höijer J; Ärnlöv J; Zethelius B; Svensson P
    Hypertension; 2015 Sep; 66(3):681-6; discussion 445. PubMed ID: 26150437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people.
    Rapsomaniki E; Timmis A; George J; Pujades-Rodriguez M; Shah AD; Denaxas S; White IR; Caulfield MJ; Deanfield JE; Smeeth L; Williams B; Hingorani A; Hemingway H
    Lancet; 2014 May; 383(9932):1899-911. PubMed ID: 24881994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Population-Level Blood Pressure Treatment Strategies on Cardiovascular and Cognitive Outcomes.
    Burke JF; Sussman JB; Yaffe K; Hayward RA; Giordani BJ; Galecki AT; Whitney R; Briceño EM; Gross AL; Elkind MSV; Manly JJ; Gottesman RF; Gaskin DJ; Sidney S; Levine DA
    Circ Cardiovasc Qual Outcomes; 2024 Jun; 17(6):e010288. PubMed ID: 38813695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Frequency of Atherosclerotic Cardiovascular and Safety Events With Systolic Blood Pressure <120mm Hg Versus 135-139mm Hg in a Systolic Blood Pressure Intervention Trial Primary Prevention Subgroup.
    Plante TB; Juraschek SP; Miller ER; Appel LJ; Cushman M; Littenberg B
    Am J Cardiol; 2018 Oct; 122(7):1185-1190. PubMed ID: 30115425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS).
    Nielsen OW; Sajadieh A; Sabbah M; Greve AM; Olsen MH; Boman K; Nienaber CA; Kesäniemi YA; Pedersen TR; Willenheimer R; Wachtell K
    Circulation; 2016 Aug; 134(6):455-68. PubMed ID: 27486164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fasting blood glucose, diabetes treatment, blood pressure and anti-hypertension treatment on cardiovascular disease incidence: a 30-year follow-up study of 740 incident patients with Type 2 diabetes.
    Jansson SP; Andersson DK; Svärdsudd K
    Diabet Med; 2013 Mar; 30(3):349-57. PubMed ID: 23278364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Frequency of Atherosclerotic Cardiovascular Disease Events Among Primary and Secondary Prevention Subgroups of the Systolic Blood Pressure Intervention Trial.
    Plante TB; Juraschek SP; Zakai NA; Tracy RP; Cushman M
    Am J Cardiol; 2019 Dec; 124(11):1701-1706. PubMed ID: 31575423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Differences in Associations of Blood Pressure Components in Young Adulthood With Incident Cardiovascular Disease by Middle Age: Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Yano Y; Reis JP; Tedla YG; Goff DC; Jacobs DR; Sidney S; Ning H; Liu K; Greenland P; Lloyd-Jones DM
    JAMA Cardiol; 2017 Apr; 2(4):381-389. PubMed ID: 28199497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
    Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study.
    Honda T; Chen S; Hata J; Yoshida D; Hirakawa Y; Furuta Y; Shibata M; Sakata S; Kitazono T; Ninomiya T
    J Atheroscler Thromb; 2022 Mar; 29(3):345-361. PubMed ID: 33487620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.